Vnitr Lek 2012, 58(2):140-144

Medicines and thyroid gland

M. Tajtáková
I. interná klinika Lekárskej fakulty UPJŠ a UN Košice, Slovenská republika, prednostka prof. MUDr. Ivica Lazúrová, CSc.

From their primary pharmacological effect, many drugs may also affect the thyroid gland function or the results of thyroid function tests. In addition to the drugs with a known effect on thyroid gland, including thionamides, thyroid hormones, recombinant TSH, iodine, iodide, amiodarone, lithium and heparin, novel compounds, including tyrosin-kinase inhibitors, immunomodulators and cytokines also have adverse effects on the thyroid gland. Novel drugs are then associated with new types of adverse thyroid effects.

Keywords: drugs; thyroid gland dysfunction; tyrosine kinase inhibitors; immunomodulators; cytokines

Received: July 13, 2011; Accepted: September 12, 2011; Published: February 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tajtáková M. Medicines and thyroid gland. Vnitr Lek. 2012;58(2):140-144.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Heufelder AE, Wiersinga WM. Störungen der Schilddrüsenfunktion: durch Amiodaron Pathogenese, Diagnostik and Therapie. Dtsch Arztebl 1999; 96: 34-41.
    2. Harjai KJ, Licata AA. Amiodarone induced hyperthyroidism: a case series and brief review of literature. Pacing Clin Electrophysiol 1996; 19: 1548-1554. Go to original source... Go to PubMed...
    3. Eskes SA, Wiersinga WM. Amiodarone and thyroid. Best Pract Res Clin Endocrinol Metab 2009; 23: 735-731. Go to original source... Go to PubMed...
    4. Barbesino G. Drugs affecting thyroid function. Thyroid 2010; 20: 763-700. Go to original source... Go to PubMed...
    5. Joe G, Shashank RJ. Drugs and thyroid. JAPI 2007; 55: 215-221. Go to PubMed...
    6. Bocchetta A, Loviselli A. Lithium treatment and thyroid abnormalities. Clin Pract Epidemiol Ment Health 2006; 2: 23. Go to original source... Go to PubMed...
    7. Cappelli C, Rotondi M, Pirola I et al. TSH-Lowering Effect of Metformin in Type 2 Diabetic Patients. Differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care 2009; 32: 1589-1590. Go to original source... Go to PubMed...
    8. Morteza Taghavi S, Rokni H, Fatemi S. Metformin decreases thyreotropin in overweight women with polycystic ovarian syndrome and hypothyroidism. Diab Vasc Dis Res 2011; 1: 47-48. Go to original source... Go to PubMed...
    9. Kebebew E, Lindsay S, Clark OH et al. Results of rosiglitazone therapy in patients with thyreo-globulin-positive and radioiodine-negative advanced differentiated thyroid cancer. Thyroid 2009; 19: 953-956. Go to original source... Go to PubMed...
    10. Antonelli A, Ferrari SM, Fallahi P et al. Cytokines (interferon γ and tumor necrosis factor &alpha)-induced nuclear factor-kB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone. Metabolism 2011; 60: 277-283. Go to original source... Go to PubMed...
    11. Laji K, Rhidha R, John R et al. Abnormal serum free thyroid hormone levels due to heparin administration. Q J Med 2001; 94: 471-473. Go to original source... Go to PubMed...
    12. Wu X, Schott M, Liu C et al. Statins decrease the aberrant HLA-DR expression on thyreocytes from patients with Hashimoto's thyroiditis. Horm Metab Res 2008; 40: 838-841. Go to original source... Go to PubMed...
    13. Gullu S, Emral R, Bastemir M et al. In vivo and in vitro effects of statins on lymphocytes in patients with Hashimoto's thyroiditis. Eur J Endocrinol 2005; 153: 41-48. Go to original source... Go to PubMed...
    14. Medical News Today. http://www.medicalnewstoday.com/. 2009.
    15. Eker SS, Akkaya C, Ersoy C et al. Reversible escitalopram-induces hypothyroidism. Gen Hosp Psychiatry 2010; 32: 559. Go to original source... Go to PubMed...
    16. Shinohara N, Takahashi M, Kamishima T et al. The incidence and mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma. Br J Cancer 2011; 104: 241-247. Go to original source... Go to PubMed...
    17. Torino F, Corsello SM, Longo R et al. Hypothyroidism related to tyrosinekinase inhibitors: an emerging toxic effect of targeted therapy. Nat Rev Clin Oncol 2009; 6: 219-228. Go to original source... Go to PubMed...
    18. Makita N, Miyakawa M, Fujita T et al. Sunitinib induces hypothyroidism with a markedly reduced vascularity. Thyroid 2010; 20: 323-326. Go to original source... Go to PubMed...
    19. Sherman SI. Thyrosine kinase inhibitors and the thyroid. Best Pract Res Clin Endocrinol Metab 2009; 23: 713-722. Go to original source... Go to PubMed...
    20. Rogiers A, Wolter P, Op de Beeck K et al. Shrinkage of thyroid volume in sunitinib-treated patients with renal-cell carcinoma: a potential marker of irreversible thyroid dysfunction? Thyroid 2010; 20: 317-322. Go to original source... Go to PubMed...
    21. Sato S, Muraishi K, Tani J et al. Clinical characteristics of thyroid abnormalities induced by sunitinib treatment in Japanes patients with renal cell carcinoma. Endocr J 2010; 57: 873-880. Go to original source... Go to PubMed...
    22. Sakurai K, Fukazawa H, Arihara Z et al. Sunitinib-induced thyreotoxicosis followed by persistent hypothyroidism with shrinkage of thyroid volume. Tohoku J Exp Med 2010; 222: 39-44. Go to original source... Go to PubMed...
    23. Lio S. Thyroid function and sunitinib treatment. In: In Endocrine Abstracts ITC 2010; 207.
    24. van Doorn L, Eskens FA, Visser TJ et al. Sorafenib induced thyroiditis in two patients with hepatocellular carcinoma. Thyroid 2011; 21: 197-202. Go to original source... Go to PubMed...
    25. Faris JE, Moore AF, Daniels GH. Sunitinib (sutent)-induced thyreotoxicosis due to destructive thyroiditis: a case report. Thyroid 2007; 17: 1147-1149. Go to original source... Go to PubMed...
    26. Mannavola D, Coco P, Vannucchi G et al. A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake. J Clin Endocrinol Metab 2007; 92: 3531-3534. Go to original source... Go to PubMed...
    27. Choi EH, Kim WG, Kim EY et al. The effect of sunitinib on growth and proliferation of normal rat thyroid cell line, FRTL-5. In: Endocrine Abstracts ITC 2010: 207.
    28. Wong E, Rosen LS, Mulay M et al. Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity. Thyroid 2007; 17: 351-355. Go to original source... Go to PubMed...
    29. Abdulrahman RM, Verloop H, Hoftijzer H et al. Sorafenib-induced hypothyroidism is associated with increased typ 3 deiodination. J Clin Endocrinol Metab 2010; 95: 3758-3762. Go to original source... Go to PubMed...
    30. Kim TD, Schwarz M, Nogai H et al. Thyroid dysfunction caused by second-generation tyrosinekinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia. Thyroid 2010; 20: 1209-1214. Go to original source... Go to PubMed...
    31. Wotherspoon F, Kajicek JP, Flanagan DE. Autoimmune thyroid disease following treatment of multiple sclerosis with Campath-1H. In: Endocrine Abstracts BES 2005; 9: 207.
    32. Jones JL, Phuah CL, Cox AL et al. IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-lH). J Clin Invest 2009; 119: 1852-1853. Go to original source...
    33. Bongartz T, Sutton AJ, Sweeting MJ et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006; 295: 2275-2285. Go to original source... Go to PubMed...
    34. Yu S, Fang Y, Sharav T et al. CD8+ T cells induce thyroid epithelial cell hyperplasia and fibrosis. J Immunol 2011; 186: 2655-2662. Go to original source... Go to PubMed...
    35. Remicade side effect: Thyroid cancer. http://www.ehealthme.com/. 2011.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.